A review of China's compensation program for adverse reactions following immunization
- PMID: 37608980
- PMCID: PMC10440378
- DOI: 10.3389/fpubh.2023.1211976
A review of China's compensation program for adverse reactions following immunization
Abstract
Vaccination is a compelling measure to battle infectious diseases and protect public health. However, because of the constraints on human cognition, it is difficult to ensure that vaccines are safe. Adverse reactions to immunization can cause individual injury. In numerous countries, no-fault programs have been established to compensate individuals for vaccine-related injuries. China also established a vaccine injury compensation system with its own unique characteristics. The Vaccine Administration Law was promulgated in 2019 to establish a compensation system for those who experience adverse reactions following immunization; nevertheless, the compensation system is imperfect. Even when the applicable terms are applied to deal with vaccine-related injuries, some issues remain, such as unreasonable diagnosis and evaluation procedures for adverse reactions, excessively strict standards regarding proof and inconsistent compensation standards across the country. Therefore, to provide effective compensation for vaccine recipients, it is important to clarify the standards of proof and establish a sensible vaccine injury compensation system that includes Corona Virus Disease 2019 vaccine-injury compensation.
Keywords: Corona virus disease 2019; adverse reaction following immunization; compensation system; vaccine administration law; vaccine injury.
Copyright © 2023 Yingxiong.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries.Vaccine. 2019 Jul 18;37(31):4370-4375. doi: 10.1016/j.vaccine.2019.06.018. Epub 2019 Jun 15. Vaccine. 2019. PMID: 31213377
-
No-Fault Compensation for Adverse Events Following Immunization: A Review of Chinese Law And Practice.Med Law Rev. 2017 Feb 1;25(1):99-114. doi: 10.1093/medlaw/fwx001. Med Law Rev. 2017. PMID: 28177508 Review.
-
COVID-19 Vaccine Injury Compensation Program: Lessons Learned From a Review of 10 Implementing Countries.J Korean Med Sci. 2024 Apr 8;39(13):e121. doi: 10.3346/jkms.2024.39.e121. J Korean Med Sci. 2024. PMID: 38599598 Free PMC article. Review.
-
Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates.Vaccine. 2025 Apr 11;52:126830. doi: 10.1016/j.vaccine.2025.126830. Epub 2025 Mar 3. Vaccine. 2025. PMID: 40037238
-
Vaccine injury compensation: the Israeli case.Isr J Health Policy Res. 2021 Sep 13;10(1):54. doi: 10.1186/s13584-021-00490-w. Isr J Health Policy Res. 2021. PMID: 34517920 Free PMC article.
Cited by
-
Comparison of regulatory approval system for medicines in emergency among Japan, the United States, the United Kingdom, Europe, and China.PLoS One. 2024 Sep 16;19(9):e0309992. doi: 10.1371/journal.pone.0309992. eCollection 2024. PLoS One. 2024. PMID: 39283913 Free PMC article.
References
-
- World Health Organization . WHO coronavirus (COVID-19) dashboard. (2023). Available at: https://covid19.who.int/ (Accessed April 5, 2023).
-
- China CDC. Overview of surveillance information on adverse reactions of COVID-19 vaccines in China (as of 30 April 2021). (2021). Available at: https://www.chinacdc.cn/jkzt/ymyjz/ymyjjz_6758/202105/t20210528_230911.html (Accessed April 10, 2023).
-
- Zhang L, Li KL, Li Y, Fan CX, Li Y, Ren MR, et al. . Surveillance of adverse events following immunization in China, 2020. Chin J Vaccines Immunization. (2022) 28:208–18. doi: 10.19914/j.CJVI.2022041 - DOI
-
- Sun YH. The discussion about the proof burden of causal relationship between mandatory vaccination and damage. Hebei Law Sci. (2015) 33:72–9. doi: 10.16494/j.cnki.1002-3933.2015.10.006 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical